Physician profile
Edwin Mandieka
NPI 1295239945
$15,070.20
in general payments reported to CMS, 2019-2025
14 companies · $14K in 2025
The $14K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.40 · 2024: $735 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Food and Beverage: $3,307 · Travel and Lodging: $1,747 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Food and Beverage | $3,306.99 |
| Travel and Lodging | $1,746.81 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,600.61 | 2025 | Corevalve Evolut R |
| Stryker Corporation | $1,620.27 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Clottriever Bold Catheter |
| Edwards Lifesciences Corporation | $1,207.57 | 2025 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $787.81 | 2024-2025 | Optis, Supera, Xience Skypoint |
| Boston Scientific Corporation | $159.71 | 2024 | |
| Inari Medical, INC. | $145.55 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Recor Medical INC | $144.69 | 2024 | Paradise Renal Denervation System |
| Penumbra, INC. | $141.22 | 2024 | Indigo System |
| Chiesi USA, INC. | $70.29 | 2024 | Kengreal |
| Cook Medical LLC | $52.63 | 2025 | Zilver Ptx |
| Novo Nordisk INC | $50.00 | 2025 | Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $50.00 | 2025 | Lifevest |
| Amgen INC. | $24.45 | 2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $15.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Mandieka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.